Jonathan Fleming

Jonathan Fleming is a seasoned executive and investor in the life sciences industry with extensive experience in founding, financing, and operating breakthrough companies. He currently serves as the Chairman of the Board for several early-stage life science companies, including AutonomUS, Inc.13

Professional Experience

Fleming's career spans over 30 years, during which he has:

• Raised more than $1 billion for early-stage investment funds
• Made over 200 investments resulting in 20+ IPOs and 40+ M&A events
• Worked with seven Nobel laureates to create and build companies based on their work2

Current Roles

Jonathan Fleming currently holds several leadership positions:

• Chairman of the Board for AutonomUS, Inc.
• Chairman of the Board for Diceros Therapeutics
• Chairman of the Board for Onc.AI
• Chairman of the Board for Aquaculture Research Corporation
• Chairman of the Board for EnClear Therapies
• Board member at CONTINUUS Pharmaceuticals, Inc1

Previous Positions

Fleming's past roles include:

• President and CEO of Q-State Biosciences
• Executive Chairman of QurAlis Inc.
• Managing Partner of Oxford Bioscience Partners for 19 years
• Founding General Partner of MVP Ventures in Boston, MA
• Co-founder of Medica Venture Partners and Korea Seoul Life Science Fund1

Academic Involvement

Since 2002, Fleming has been a Senior Lecturer at the MIT Sloan School of Management, where he co-teaches a class on business strategy for life science managers.12

Education

• Master's degree in Public Administration from Princeton University's Woodrow Wilson School of Public and International Affairs
• Bachelor's degree in Political Science from the University of California, Berkeley12

Jonathan Fleming's LinkedIn profile can be found under the username jonathan-fleming-9a487256.3